Zimmer Biomet Q2 spine sales down 6.2% — 5 things to know

Zimmer Biomet reported a net sales decrease of 0.9 percent to $1.99 billion during the second quarter.

Five things to know:

1. Spine and craniomaxillofacial sales decreased 6.2 percent to $186 million compared to the same period last year.

2. Surgical, sports medicine, extremities and trauma sales increased 2.5 percent to $444 million.

3. Hip sales decreased 1.5 percent to $479 million and knee sales rose just 0.1 percent to $704 million.

4. Net earnings decreased 28.7 percent to $131.9 million for the same period last year.

5. Zimmer Biomet expects to hit its weighted average market growth rate six months ahead of schedule.

More articles on devices:
Johnson & Johnson, Stryker & more: How 8 companies are performing in spine
DJO, SeaSpine & more: 4 device company launches, releases
7 key updates on Globus Medical in 2019